secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001615219-24-000076
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius raises ~$1.5M to meet Nasdaq minimum equity requirement after being below $2.5M threshold
--------------------------------------------------------------------------------

- As of June 30, 2024, stockholders' equity was $2,375,353, below Nasdaq's $2.5M minimum.
- Sold 564,730 shares for gross proceeds of ~$1.5M via at-the-market offering to restore compliance.
- Company believes it now complies with Nasdaq Listing Rule 5550(b)(1) after the financing.
- Nasdaq will monitor; if next 10-Q shows non-compliance, common stock may be delisted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/0001615219-24-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/flks-20240813.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer